These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26725095)

  • 1. Increased expression of phosphatidylethanolamine-binding protein 4 (PEBP4) strongly associates with human gliomas grade.
    Huang RQ; Shi DL; Huang W; Chen F; Lu YC
    J Neurooncol; 2016 Apr; 127(2):235-42. PubMed ID: 26725095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
    Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
    Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
    Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M
    J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of PEBP4 inhibits human glioma cell growth and invasive potential via ERK1/2 signaling pathway.
    Huang RQ; Wang SQ; Zhu QB; Guo SC; Shi DL; Chen F; Fang YC; Chen R; Lu YC
    Mol Carcinog; 2019 Jan; 58(1):135-143. PubMed ID: 30255656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Slit2 and Robo1 expression as biomarkers for assessing prognosis in brain glioma patients.
    Liu L; Li W; Geng S; Fang Y; Sun Z; Hu H; Liang Z; Yan Z
    Surg Oncol; 2016 Dec; 25(4):405-410. PubMed ID: 27916173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
    Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
    Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated expression of cry1 and cry2 in human gliomas.
    Luo Y; Wang F; Chen LA; Chen XW; Chen ZJ; Liu PF; li FF; Li CY; Liang W
    Asian Pac J Cancer Prev; 2012; 13(11):5725-8. PubMed ID: 23317246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.
    Lin L; Wang G; Ming J; Meng X; Han B; Sun B; Cai J; Jiang C
    Tumour Biol; 2016 Nov; 37(11):15333-15339. PubMed ID: 27704357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Roundabout4 predicts poor prognosis of primary glioma patients via correlating with microvessel density.
    Cai H; Xue Y; Liu W; Li Z; Hu Y; Li Z; Shang X; Liu Y
    J Neurooncol; 2015 May; 123(1):161-9. PubMed ID: 25859844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
    He J; Deng Y; Yang G; Xie W
    J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression level of human miR-34a correlates with glioma grade and prognosis.
    Gao H; Zhao H; Xiang W
    J Neurooncol; 2013 Jun; 113(2):221-8. PubMed ID: 23529798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas.
    Han MZ; Huang B; Chen AJ; Zhang X; Xu R; Wang J; Li XG
    Oncol Rep; 2017 Feb; 37(2):903-912. PubMed ID: 28075478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients.
    Wang Q; Wang L; Li D; Deng J; Zhao Z; He S; Zhang Y; Tu Y
    Cancer Epidemiol; 2013 Feb; 37(1):79-84. PubMed ID: 22999822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of p42.3 in low- and high-grade gliomas.
    Wan W; Xu X; Jia G; Li W; Wang J; Ren T; Wu Z; Zhang J; Zhang L; Lu Y
    World J Surg Oncol; 2014 Jun; 12():185. PubMed ID: 24927751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas.
    Zeng J; Zhang XK; Chen HD; Zhong ZH; Wu QL; Lin SX
    Oncotarget; 2016 Feb; 7(8):8944-55. PubMed ID: 26771840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
    Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
    Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.
    Yang X; Li D; Cheng S; Fan K; Sheng L; Zhang J; Feng B; Xu Z
    Tumour Biol; 2014 Nov; 35(11):11091-5. PubMed ID: 25099618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RIZ1: a potential tumor suppressor in glioma.
    Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
    BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative and Quantitative Analysis of IDH1 Mutation in Progressive Gliomas by Allele-Specific qPCR and Western Blot Analysis.
    Perrech M; Dreher L; Röhn G; Stavrinou P; Krischek B; Toliat M; Goldbrunner R; Timmer M
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819828396. PubMed ID: 30943868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of stem cell marker CD133 determined by promoter methylation but not by immunohistochemical expression in malignant gliomas.
    Wu X; Wu F; Xu D; Zhang T
    J Neurooncol; 2016 Apr; 127(2):221-32. PubMed ID: 26757925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.